Ensign Peak Advisors Inc lessened its position in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 3.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 103,070 shares of the company's stock after selling 4,192 shares during the quarter. Ensign Peak Advisors Inc owned 0.05% of DocuSign worth $9,270,000 at the end of the most recent reporting period.
A number of other institutional investors also recently bought and sold shares of the company. FMR LLC boosted its stake in shares of DocuSign by 178.2% during the 4th quarter. FMR LLC now owns 6,101,024 shares of the company's stock worth $548,726,000 after acquiring an additional 3,908,139 shares during the last quarter. Invesco Ltd. raised its holdings in DocuSign by 283.9% in the 4th quarter. Invesco Ltd. now owns 3,447,275 shares of the company's stock worth $310,048,000 after purchasing an additional 2,549,310 shares during the period. Norges Bank purchased a new position in DocuSign during the fourth quarter valued at $223,196,000. Arrowstreet Capital Limited Partnership increased its position in DocuSign by 201.6% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,158,311 shares of the company's stock worth $194,118,000 after buying an additional 1,442,639 shares in the last quarter. Finally, Jericho Capital Asset Management L.P. raised its stake in shares of DocuSign by 34.0% in the fourth quarter. Jericho Capital Asset Management L.P. now owns 4,754,753 shares of the company's stock worth $427,642,000 after buying an additional 1,205,500 shares during the period. Institutional investors own 77.64% of the company's stock.
DocuSign Stock Performance
Shares of DOCU opened at $87.86 on Tuesday. The stock has a market capitalization of $17.79 billion, a PE ratio of 18.12, a P/E/G ratio of 6.94 and a beta of 1.21. The company's fifty day moving average is $80.26 and its 200 day moving average is $84.71. DocuSign, Inc. has a fifty-two week low of $48.70 and a fifty-two week high of $107.86.
DocuSign (NASDAQ:DOCU - Get Free Report) last posted its earnings results on Thursday, March 13th. The company reported $0.86 earnings per share for the quarter, topping analysts' consensus estimates of $0.84 by $0.02. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The firm had revenue of $776.25 million for the quarter, compared to the consensus estimate of $760.94 million. During the same period in the previous year, the firm posted $0.76 EPS. The business's quarterly revenue was up 9.0% on a year-over-year basis. As a group, research analysts forecast that DocuSign, Inc. will post 1.17 earnings per share for the current year.
Wall Street Analyst Weigh In
DOCU has been the subject of several analyst reports. JMP Securities reissued a "market outperform" rating and issued a $124.00 target price on shares of DocuSign in a report on Thursday, April 17th. William Blair reissued an "outperform" rating on shares of DocuSign in a report on Monday, April 21st. Royal Bank of Canada restated a "sector perform" rating and issued a $90.00 price target on shares of DocuSign in a research note on Friday, March 14th. Hsbc Global Res upgraded shares of DocuSign from a "moderate sell" rating to a "hold" rating in a research report on Friday, April 11th. Finally, Citigroup boosted their target price on shares of DocuSign from $113.00 to $115.00 and gave the stock a "buy" rating in a report on Friday, March 14th. One analyst has rated the stock with a sell rating, eleven have issued a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $92.46.
View Our Latest Analysis on DocuSign
Insider Activity
In other news, insider James P. Shaughnessy sold 7,500 shares of the stock in a transaction on Tuesday, April 1st. The shares were sold at an average price of $81.31, for a total value of $609,825.00. Following the sale, the insider now owns 45,875 shares of the company's stock, valued at approximately $3,730,096.25. This represents a 14.05% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Teresa Briggs sold 534 shares of DocuSign stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $87.41, for a total transaction of $46,676.94. Following the transaction, the director now directly owns 8,270 shares of the company's stock, valued at approximately $722,880.70. This represents a 6.07% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 55,851 shares of company stock valued at $4,607,439. 1.01% of the stock is currently owned by insiders.
DocuSign Company Profile
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Further Reading
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.